Adjunctive hyperbaric oxygen therapy for irradiated rat calvarial defects.

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Surgical Oncology

Background:

• Radiotherapy can impair bone healing, particularly in craniofacial reconstructions.
• Fibroblast growth factor-2 (FGF-2) and hyperbaric oxygen (HBO) therapy are potential therapeutic modalities for enhancing tissue repair.
• Biphasic calcium phosphate (BCP) is a commonly used bone graft material.

Purpose of the Study:

• To histologically evaluate bone regeneration in irradiated rat calvarial defects.
• To assess the efficacy of FGF-2 and BCP blocks, with or without HBO therapy, in promoting bone healing.

Main Methods:

• Irradiated calvarial defects were created in rats and treated with FGF-2 or BCP blocks.
• Animals were divided into HBO and non-HBO (NHBO) groups.
• Defects were analyzed radiographically and histologically after 4 weeks of healing.

Main Results:

• FGF-2 significantly enhanced new bone formation compared to controls.
• BCP blocks showed no improvement in bone regeneration.
• HBO therapy showed a trend towards increased angiogenesis but minimal effect on bone formation.
• FGF-2 efficacy was not significantly improved by adjunctive HBO therapy.

Conclusions:

• FGF-2 promotes bone regeneration and angiogenesis in irradiated calvarial defects.
• HBO therapy benefits angiogenesis but has limited impact on bone regeneration in this model.
• The combination of FGF-2 and HBO did not yield superior results compared to FGF-2 alone.